The effects of prepuberal gonadectomy on pituitary secretion of ACTH were studied in adult male rats. Plasma concentration of ACTH in unstressed adrenalectomized rats was increased following orchiectomy to 197% (95% confidence limits 134-289%) of the control level. Higher plasma ACTH concentrations were also observed in castrated animals with adrenals intact after the acute stress of ether anesthesia when compared to similarly stressed controls ( 159%; 121-215%). In both experiments, replacement with testosterone reversed the response to orchiectomy. Unstimulated release of ACTH in vitro by whole pituitary glands from orchiectomized donors, without or with testosterone replacement in vivo, did not differ from that of control glands. Addition of stalk-median eminence extract to the incubating glands, however, resulted in a greater R EMOVAL of the ovaries from rats results in decreased synthesis and release of ACTH ( 1). In addition, adrenal secretion of corticosterone is also significantly depressed, independent of changes in ACTH secretion ( 2) . These effects are reversed with estradiol administration. The data thus demonstrate stimulation of the pituitary-adrenal system by estrogen at two different sites, i.e., significant and separable enhancement of secretion of both pituitary ACTH and adrenal corticosterone.
Less information is available concerning changes in pituitary
REMOVAL of the ovaries from rats results in decreased synthesis and release of ACTH ( 1). In addition, adrenal secretion of corticosterone is also significantly depressed, independent of changes in ACTH secretion ( 2) . These effects are reversed with estradiol administration. The data thus demonstrate stimulation of the pituitary-adrenal system by estrogen at two different sites, i.e., significant and separable enhancement of secretion of both pituitary ACTH and adrenal corticosterone. Less information is available concerning changes in pituitary ACTH secretion in relation to testicular function. Kitay ( 3) has shown that adrenal corticosterone secretion is depressed following orchiectomy and that this defect is reversed by testosterone replacement. However, in contrast, pituitary ACTH content and adrenal size are increased in castrates suggesting increased synthesis and release of ACTH. The studies of Zizine suggested that testosterone administration inhibits ACTH release, as indicated by decreased adrenal ascorbic acid depletion after stress ( 4), and decreased compensatory adrenal hypertrophy after unilateral adrenalectomy ( 5). In the present study, blood levels of ACTH were measured directly in orchiectomized and orchiectomized, testosterone-treated rats to obtain direct evidence concerning the influence of testosterone on ACTH output by the pituitary gland. In vitro experiments were employed to assess the manner in which testosterone alters ACTH secretion.
Materials and Methods
Male rats of the Sherman strain were used as experimental animals; female rats of the Sprague-Dawley strain were used for in vitro bioassay procedures, while male animals were used for in vivo assays. The animals were given a diet of Purina Laboratory Chow and water ad lib. and maintained at a constant temperature of 22 C + 0.5. Gonadectomy was performed at 23 days of age with no further manipulation 1024 (except removal of wound clips) for the next 6 weeks. Control animals were sham-operated at the same age. Testosterone phenylacetate (Perandren, Ciba) was administered to gonadectomized male rats in the form of a single, sc injection of 5 mg/ lO0g body weight. Control rats were not injected, since preliminary experiments revealed no effects from a single injection of the vehicle ( distilled water) alone. Determinations were made 14 days after testosterone injection. Plasma concentrations of ACTH in resting animals are at or below the lower levels of sensitivity of the assay method presently in use. Therefore, bilaterally adrenalectomized rats (absence of corticosteroid feedback raises blood ACTH to the range of assay) were used to test the effect of orchiectomy on plasma concentrations of ACTH. Depot injections of testosterone phenylacetate were given on the same day to one-half of the gonadectomized-adrenalectomized animals. Two weeks after adrenalectomy, blood was collected without stress by decapitation within 20 sec after handling. A second method of elevating blood levels of ACTH to detectable concentrations is the application of an acute stressful stimulus. This procedure tests the overall responsiveness of the hypothalamohypophyseal system since the magnitude of the increase in blood ACTH is a summation of any modifications in hypothalamic ( CRF) and pituitary (ACTH) secretion. Rats with intact adrenals were subjected to ether anesthesia as standardized by Wells et al. ( 6) . Blood was collected upon decapitation 2.5 min after the onset of anesthesia to obtain peak post-stress plasma concentrations of ACTH ( 7). All blood specimens were centrifuged immediately in the cold in siliconecoated glass tubes. Plasma from each experimental group of 5-6 animals was pooled, frozen at -5 C, and subsequently assayed for ACTH according to the in vivo bioassay method of Vernikos-Danellis et al. ( (Table 2) , nor is any effect observed after testosterone replacement in vivo. Addition of hypothalamic extract ( equal to 3 / 5 SME) to the incubating glands consistently resulted in a 2-to 3-fold increase in ACTH output. Direct quantitative assays of the potency of the uniform SME used in these experiments were not made. Compared to the response of control glands stimulated with SME, the release of ACTH by pituitaries from orchiectomized rats is enhanced ( 162 % ; p < 0.05). / n vivo replacement with testosterone resulted in lowering of release toward but not to the control level. Bilateral adrenalectomy did not alter the pattern of response associated with removal of the testes (Table 2) . ACTH release by unstimulated pituitary glands from orchiectomized, adrenalectomized rats was unchanged. Again, in the presence of SME, a significant hyperresponse ( 134% ; p < 0.05) was obtained in the castrate group compared to the control. Each potency is expressed as a percentage of ACTH released from pituitary glands receiving diluent (10 µl ethanol) added in vitro. 95% confidence limits are indicated in parentheses. Pool of 4 pituitary glands per experiment; where indicated 3/5 SME added per pool of 4 pituitaries. In an additional experiment (Table 3) , testosterone was added directly in vitro to incubating pituitary glands from both intact and orchiectomized rats. The responses were variable, but in no instance was a significant change in ACTH output obtained compared to control ( diluent added) performance. Hypothalamic content of corticotropinreleasing activity. To determine whether changes in hypothalamic storage of CRA might be a factor in increased secretion of ACTH in vivo after prepuberal orchiectomy, the hypothalamic content of CRA was determined. Comparable aliquots of SME extract from the three groups of experimental animals were assayed in vitro. Extracts from intact, orchiectomized (90% ; 73-112 % ) and orchiectomized, testosterone-injected (114%; 62-208%) rats contained similar quantities of corticotropin-releasing material.
Discussion
The data indicate that pituitary secretion of ACTH is increased following prepuberal orchiectomy in rats subjected to either chronic bilateral adrenalectomy or an acute stressful stimulus when compared to the response of intact controls. Moreover, testosterone administered as replacement prevents the increment in plasma ACTH levels attributable to orchiectomy. . Plasma corticosterone-binding-globulin activity is increased (15), but biological half-life is shortened ( 3) and the rate of hepatic metabolism of corticosterone is accelerated ( 3). The outcome is that castration results in no net change in plasma concentrations of corticosterone ( 3). This applies to animals at rest, after acute stress, or after stimulation with ACTH. Therefore, if plasma concentrations of corticosterone were taken as the indicator of activity of the pituitary-adrenal axis, the testes would seem to be of little consequence. The data presented in this report contribute to the concept that testosterone exerts complex, balanced effects on the hypothalamo-hypophyseal-adrenal system.
